BioCentury | Oct 31, 2019
Financial News

Oyster Point, RAPT post gains after pricing IPOs at low end of range

...its largest shareholder; underwriters are BMO Capital Markets, Wells Fargo and UBS. Spun out of Flexus Biosciences Inc....
BioCentury | Jul 9, 2019
Financial News

July 8 Financial Quick Takes: IGM raises mega-round; plus Mirium, Fulcrum set IPO ranges and more

...with cell type-specific expression guided by encoded 'if', 'and', or 'or' logic gates. Allison Johnson, Senior Writer Flexus Biosciences Inc. Fulcrum...
BioCentury | Jul 8, 2019
Financial News

On heels of series C extension, RAPT Therapeutics files for IPO

...Discovery David Wustrow became SVP of drug discovery and preclinical development. RAPT spun out of Flexus Biosciences Inc....
BioCentury | Aug 18, 2017
Company News

Arcus gets rights to PD-1 mAb from WuXi, Gloria

...to the antibody. Arcus founders Terry Rosen and Juan Jaen also founded cancer immunotherapy company Flexus Biosciences Inc....
BioCentury | Aug 17, 2017
Company News

Arcus gets rights to PD-1 mAb from WuXi, Gloria

...June 7) . Arcus founders Terry Rosen and Juan Jaen also founded cancer immunotherapy company Flexus Biosciences Inc....
BioCentury | Aug 10, 2017
Emerging Company Profile

Flexing against suppression

...dominating the immuno-oncology space. Armed with $79 million in series A and B funds, the Flexus Biosciences Inc....
...targeting Tregs and myeloid-derived suppressor cells Disease focus: Cancer Clinical status: Preclinical Founded: 2015 by Flexus Biosciences Inc....
...at the annual meeting of the American Association for Cancer Research (2017) Karen Tkach Tuzman, Senior Writer Flexus Biosciences Inc. RAPT...
BioCentury | Apr 12, 2017
Clinical News

BMS-986205: Ph I/IIa data

...Association for Cancer Research meeting in Washington, D.C. BMS gained BMS-986205 through its acquisition of Flexus Biosciences Inc....
BioCentury | Apr 7, 2017
Finance

To market, to market

...prove that they have combinations,” Loncar said. Bristol-Myers gained BMS-986205 through its 2015 acquisition of Flexus Biosciences Inc....
BioCentury | Aug 29, 2016
Financial News

Arcus discloses $119.7M in financings

...to the clinic, but declined to disclose specific indications. Rosen was CEO at immunotherapy company Flexus BioSciences Inc....
BioCentury | May 2, 2016
Finance

Flexus redux

...Venture backers of Flexus Biosciences Inc. are back for round two with spinout FLX Bio Inc. This time...
Items per page:
1 - 10 of 24
BioCentury | Oct 31, 2019
Financial News

Oyster Point, RAPT post gains after pricing IPOs at low end of range

...its largest shareholder; underwriters are BMO Capital Markets, Wells Fargo and UBS. Spun out of Flexus Biosciences Inc....
BioCentury | Jul 9, 2019
Financial News

July 8 Financial Quick Takes: IGM raises mega-round; plus Mirium, Fulcrum set IPO ranges and more

...with cell type-specific expression guided by encoded 'if', 'and', or 'or' logic gates. Allison Johnson, Senior Writer Flexus Biosciences Inc. Fulcrum...
BioCentury | Jul 8, 2019
Financial News

On heels of series C extension, RAPT Therapeutics files for IPO

...Discovery David Wustrow became SVP of drug discovery and preclinical development. RAPT spun out of Flexus Biosciences Inc....
BioCentury | Aug 18, 2017
Company News

Arcus gets rights to PD-1 mAb from WuXi, Gloria

...to the antibody. Arcus founders Terry Rosen and Juan Jaen also founded cancer immunotherapy company Flexus Biosciences Inc....
BioCentury | Aug 17, 2017
Company News

Arcus gets rights to PD-1 mAb from WuXi, Gloria

...June 7) . Arcus founders Terry Rosen and Juan Jaen also founded cancer immunotherapy company Flexus Biosciences Inc....
BioCentury | Aug 10, 2017
Emerging Company Profile

Flexing against suppression

...dominating the immuno-oncology space. Armed with $79 million in series A and B funds, the Flexus Biosciences Inc....
...targeting Tregs and myeloid-derived suppressor cells Disease focus: Cancer Clinical status: Preclinical Founded: 2015 by Flexus Biosciences Inc....
...at the annual meeting of the American Association for Cancer Research (2017) Karen Tkach Tuzman, Senior Writer Flexus Biosciences Inc. RAPT...
BioCentury | Apr 12, 2017
Clinical News

BMS-986205: Ph I/IIa data

...Association for Cancer Research meeting in Washington, D.C. BMS gained BMS-986205 through its acquisition of Flexus Biosciences Inc....
BioCentury | Apr 7, 2017
Finance

To market, to market

...prove that they have combinations,” Loncar said. Bristol-Myers gained BMS-986205 through its 2015 acquisition of Flexus Biosciences Inc....
BioCentury | Aug 29, 2016
Financial News

Arcus discloses $119.7M in financings

...to the clinic, but declined to disclose specific indications. Rosen was CEO at immunotherapy company Flexus BioSciences Inc....
BioCentury | May 2, 2016
Finance

Flexus redux

...Venture backers of Flexus Biosciences Inc. are back for round two with spinout FLX Bio Inc. This time...
Items per page:
1 - 10 of 24